Literature DB >> 1328099

Design of chimeric peptide ligands to galanin receptors and substance P receptors.

U Langel1, T Land, T Bartfai.   

Abstract

Several chimeric peptides were synthesized and found to be high-affinity ligands for both galanin and substance P receptors in membranes from the rat hypothalamus. The peptide galantide, composed of the N-terminal part of galanin and C-terminal part of substance P (SP), galanin-(1-12)-Pro-SP-(5-11) amide, which is the first galanin antagonist to be reported, recognizes two classes of galanin binding sites (KD(1) less than 0.1 nM and KD(2) approximately 6 nM) in the rat hypothalamus, while it appears to bind to a single population of SP receptors (KD approximately 40 nM). The chimeric peptide has higher affinity towards galanin receptors than the endogenous peptide galanin-(1-29) (KD approximately 1 nM) or its N-terminal fragment galanin-(1-13) (KD approximately 1 microM), which constitutes the N-terminus of the chimeric peptide. Galantide has also higher affinity for the SP receptors than the C-terminal SP fragment-(4-11) amide (KD = 0.4 microM), which constitutes its C-terminal portion. Substitution of amino acid residues, which is of importance for recognition of galanin by galanin receptors, such as [Trp2], in the galanin portion of the chimeric peptide or substitution of ([Phe7] or [Met11]-amide) in the SP portion of chimeric peptide both cause significant loss in affinity of the analogs of galantide for both the galanin- and the SP-receptors. These results suggest that the high affinity of the chimeric peptide, galantide, may in part be accounted for by simultaneous recognition/binding to both receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328099     DOI: 10.1111/j.1399-3011.1992.tb00282.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  13 in total

1.  Electrophysiological evidence for a hyperpolarizing, galanin (1-15)-selective receptor on hippocampal CA3 pyramidal neurons.

Authors:  Z Q Xu; X Ma; U Soomets; U Langel; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 2.  Galanin--a neuropeptide with inhibitory actions.

Authors:  K Kask; U Langel; T Bartfai
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

3.  Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication.

Authors:  R Kurg; J Parik; E Juronen; T Sedman; A Abroi; I Liiv; U Langel; M Ustav
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 4.  Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.

Authors:  M P McDonald; J N Crawley
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

5.  Anticonvulsant activity of a nonpeptide galanin receptor agonist.

Authors:  Külliki Saar; Andrey M Mazarati; Riina Mahlapuu; Gerd Hallnemo; Ursel Soomets; Kalle Kilk; Sven Hellberg; Margus Pooga; Bo-Ragnar Tolf; Tiejun S Shi; Tomas Hökfelt; Claude Wasterlain; Tamas Bartfai; Ulo Langel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

6.  Role of cysteine 341 and arginine 348 of GLP-1 receptor in G-protein coupling.

Authors:  Aljosa Bavec; Yang Jiang; Ulo Langel; Matjaz Zorko
Journal:  Mol Biol Rep       Date:  2006-11-14       Impact factor: 2.316

7.  Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus.

Authors:  A M Mazarati; H Liu; U Soomets; R Sankar; D Shin; H Katsumori; U Langel; C G Wasterlain
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  New high affinity peptide antagonists to the spinal galanin receptor.

Authors:  X J Xu; Z Wiesenfeld-Hallin; U Langel; K Bedecs; T Bartfai
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.

Authors:  T Bartfai; U Langel; K Bedecs; S Andell; T Land; S Gregersen; B Ahrén; P Girotti; S Consolo; R Corwin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.

Authors:  U Kahl; U Langel; T Bartfai; L Grundemar
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.